Tyrianthin 7



Compound IDCDAMM03027
Common nameTyrianthin 7
IUPAC name[4,5,11,12-tetrahydroxy-6-(hydroxymethyl)-13,31-dimethyl-27-oxo-17-pentyl-30-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy-2,7,9,14,16,28,32-heptaoxatetracyclo[27.3.1.03,8.010,15]tritriacontan-33-yl] 3-hydroxy-2-methylbutanoate
Molecular formulaC45H78O21

Experimental data

Retention time18.3
Adduct[M+Na]+
Actual mz977.497
Theoretical mz977.493
Error3.87
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score5.7847

Identifiers and class information

Inchi keyZGNFLLKKSGRAGI-UFSWUWBMNA-N
SmilesO=C1OC2C(OC(=O)C(C)C(O)C)C(OC(C)C2OC3OC(C)C(O)C(O)C3O)OC4C(O)C(O)C(OC4OC5C(O)C(O)C(OC5OC(CCCCC)CCCCCCCCC1)C)CO
SuperclassOrganic oxygen compounds
ClassOrganooxygen compounds

Plant source

  • Clitoria ternatea L.
  • Pharmacokinetic properties

    Number of descriptor values(#stars)15
    Number of non-conjugated amine groups (#amine)0
    Number of amidine and guanidine groups (#amidine)0
    Number of carboxylic acid groups (#acid)0
    Number of non-conjugated amide groups (#amide)0
    Number of rotatable bonds (#rotor)36
    Number of reactive functional groups (#rtvFG)6
    Predicted central nervous system activity (CNS)-2
    Molecular weight (mol_MW)955.099
    Computed dipole moment(dipole)6.224
    Total solvent accessible surface area (SASA)1153.25
    Hydrophobic component of SASA (FOSA)849.424
    Hydrophilic component of SASA (FISA)303.826
    Pie component of the SASA (PISA)0
    Weakly polar component of the SASA (WPSA)0
    Total solvent accesible volume (volume)2571.6
    Number of hydrogen bond donors (donorHB)8
    Number of hydrogen bond acceptors (accptHB)31.9
    Free energy of solvation of dipole (dip^2/V)0.0150629
    Index of cohesive interaction in solids (ACxDN^.5/SA)0.078237
    Globularity descriptor (glob)0.787126
    Predicted polarizability in cubic angstroms (QPpolrz)73.646
    Predicted hexadecane/gas partition coefficient (QPlogPC16)25.044
    Predicted octanol/gas partition coefficient (QPlogPoct)53.958
    Predicted water/gas partition coefficient (QPlogPw)39.758
    Predicted octanol/water partition coefficient (QPlogPo/w)-0.494
    Predicted aqueous solubility (QPlogS)-0.115
    Conformation-independent predicted aqueous solubility (CIQPlogS)-5.372
    Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-4.977
    Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)13.023
    Predicted brain/blood partition coefficient (QPlogBB)-4.875
    Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)4.535
    Predicted skin permeability, log Kp (QPlogKp)-3.663
    PM3 calculated ionization potential (IP(ev))10.412
    PM3 calculated electron affinity (EA(eV))-1.037
    Number of likely metabolic reactions (#metab)11
    Prediction of binding to human serum albumin (QPlogKhsa)-2.063
    Predicted qualitative human oral absorption (HumanOralAbsorption)1
    Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)5.126
    Solvent-accessible surface area of fluorine atoms (SAFluorine)0
    Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
    Van der Waals surface area (PSA)285.131
    Number of nitrogen and oxygen atoms (#NandO)21
    Number of violations of Lipinski’s rule of five (RuleOfFive)3
    Number of violations of Jorgensen’s rule of three (RuleOfThree)2

    Compound-target network

    Cytoscape Graph

    Protein targets associated with phytocompound

    Uniprot ID Gene name Target name TTD_ID Prediction source
    P15692VEGFAVascular endothelial growth factor AT20761SEA
    P05230FGF1Acidic fibroblast growth factorT18639SEA
    P09038FGF2Basic fibroblast growth factorT31621SEA

    Target associated diseases

    TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
    T20761DI0095Colorectal cancer[ICD-11: 2B91]P15692VEGFA
    T20761DI0365Retinopathy[ICD-11: 9B71]P15692VEGFA
    T20761DI0430Vascular system developmental anomaly[ICD-11: LA90]P15692VEGFA
    T18639DI0081Chronic arterial occlusive disease[ICD-11: BD4Z]P05230FGF1
    T18639DI0102Coronary atherosclerosis[ICD-11: BA52]P05230FGF1
    T31621DI0005Acne vulgaris[ICD-11: ED80]P09038FGF2

    Copyright © 2025